Search

Your search keyword '"Alatorre Alexander, J.A."' showing total 2 results
Start Over Author "Alatorre Alexander, J.A." Topic cancer chemotherapy
2 results on '"Alatorre Alexander, J.A."'

1. 326P Durvalumab (D) ± tremelimumab (T) + chemotherapy (CT) in 1L metastatic (m) NSCLC: Overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y).

Author

Cho, B.C., Luft, A., Alatorre Alexander, J.A., Lucien Geater, S., Laktionov, K., Sang-We, K., Ursol, G., Hussein, M., Lim Farah, L., Yang, C.T., Araujo, L.H., Saito, H., Reinmuth, N., Lai, Z., Mann, H., Shi, X., Peters, S., Garon, E.B., Mok, T.S.K., and Johnson, M.L.

Subjects
*OVERALL survival, *NON-small-cell lung carcinoma, *CANCER chemotherapy, *METASTASIS
Published
2022
Full Text
View/download PDF

2. 490MO Patient-reported outcomes of first-line selpercatinib versus chemotherapy with or without pembrolizumab in RET fusion-positive advanced non-small cell lung cancer: Interim analysis of LIBRETTO-431.

Author

Goto, K., Novello, S., Garrido Lopez, P., Dooms, C., Alatorre Alexander, J.A., Reinmuth, N., Gilligan, A., Payakachat, N., Lin, A., Cocks, K., Worthy, G., and Zhou, C.

Subjects
*NON-small-cell lung carcinoma, *PATIENT reported outcome measures, *PEMBROLIZUMAB, *CANCER chemotherapy
Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results